Teva Pharmaceutical Industries Ltd. /zigman2/quotes/205657894/composite TEVA +3.30% said Wednesday it agreed to make $110 million in payments to settle opioid claims against it by West Virginia. The company will pay $75 million over 15 years plus $8 million for legal fees. It will also provide $27 million worth of the generic version of Narcan over 10 years. Teva said the settlement is "consistent with previously announced settlement as it continues to negotiate a national settlement. Teva did not admit any liability or wrongdoing as part of the deal. Shares of Teva rose 2.2% on Wednesday morning. The stock is up 7.8% so far this year, compared to a loss of 17.2% by the S&P 500 /zigman2/quotes/210599714/realtime SPX +0.23% .